$ARVN
Arvinas Inc

2023 Q1 Form 10-K Financial Statement

#000165575923000010 Filed on February 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $32.50M $45.60M $131.4M
YoY Change 34.3% 73.18% 181.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $24.90M $15.10M $79.60M
YoY Change 23.27% -19.93% 29.22%
% of Gross Profit
Research & Development $95.30M $98.30M $315.0M
YoY Change 48.91% 58.76% 74.61%
% of Gross Profit
Depreciation & Amortization $1.200M $1.700M $6.300M
YoY Change -20.0% 31.99% 31.25%
% of Gross Profit
Operating Expenses $120.2M $113.4M $394.6M
YoY Change 42.76% 40.39% 63.06%
Operating Profit -$87.70M -$263.2M
YoY Change 46.17% 34.77%
Interest Expense $0.00 $5.700M $12.00M
YoY Change -100.0% 772.35% 11900.0%
% of Operating Profit
Other Income/Expense, Net $6.500M $600.0K $12.20M
YoY Change 490.91% -24.67% 183.72%
Pretax Income -$81.20M -$61.50M -$251.0M
YoY Change 37.86% 16.04% 31.41%
Income Tax -$400.0K $10.80M $20.90M
% Of Pretax Income
Net Earnings -$81.90M -$82.90M -$282.5M
YoY Change 29.18% 56.42% 47.91%
Net Earnings / Revenue -252.0% -181.8% -214.99%
Basic Earnings Per Share -$1.54 -$5.31
Diluted Earnings Per Share -$1.54 -$1.55 -$5.31
COMMON SHARES
Basic Shares Outstanding 53.27M shares 53.23M shares 53.20M shares
Diluted Shares Outstanding 53.30M shares 53.20M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.124B $1.205B $1.205B
YoY Change -21.35% -19.79% -19.79%
Cash & Equivalents $130.2M $81.30M $81.30M
Short-Term Investments $993.3M $1.124B $1.124B
Other Short-Term Assets $20.00M $26.90M $26.90M
YoY Change -8.68% 11.16% 11.16%
Inventory
Prepaid Expenses
Receivables $0.00 $1.000M $1.000M
Other Receivables $4.700M $7.000M $7.000M
Total Short-Term Assets $1.148B $1.240B $1.240B
YoY Change -21.19% -20.12% -20.12%
LONG-TERM ASSETS
Property, Plant & Equipment $13.40M $13.40M $17.80M
YoY Change 0.0% 5.51% 7.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $10.30M $10.80M $10.80M
YoY Change -14.88% -13.6% -13.6%
Total Long-Term Assets $27.60M $28.60M $28.60M
YoY Change -11.82% -1.72% -1.72%
TOTAL ASSETS
Total Short-Term Assets $1.148B $1.240B $1.240B
Total Long-Term Assets $27.60M $28.60M $28.60M
Total Assets $1.176B $1.269B $1.269B
YoY Change -21.0% -19.78% -19.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.30M $5.700M $5.700M
YoY Change 43.02% -81.79% -81.79%
Accrued Expenses $45.50M $60.50M $60.50M
YoY Change 50.66% 161.9% 150.0%
Deferred Revenue $214.9M $218.6M
YoY Change 8.81% 6.01%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $0.00
YoY Change
Total Short-Term Liabilities $282.9M $295.1M $295.1M
YoY Change 18.87% 12.76% 12.76%
LONG-TERM LIABILITIES
Long-Term Debt $900.0K $1.000M $1.000M
YoY Change -10.0% 0.0% 0.0%
Other Long-Term Liabilities $381.0M $407.8M $407.8M
YoY Change -27.57% -24.09% -24.09%
Total Long-Term Liabilities $900.0K $1.000M $408.8M
YoY Change -10.0% 0.0% -24.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $282.9M $295.1M $295.1M
Total Long-Term Liabilities $900.0K $1.000M $408.8M
Total Liabilities $664.8M $703.9M $703.9M
YoY Change -13.1% -12.0% -12.0%
SHAREHOLDERS EQUITY
Retained Earnings -$1.047B -$965.4M
YoY Change 40.33% 41.37%
Common Stock $100.0K $100.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $511.0M $564.9M $564.9M
YoY Change
Total Liabilities & Shareholders Equity $1.176B $1.269B $1.269B
YoY Change -21.0% -19.78% -19.78%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$81.90M -$82.90M -$282.5M
YoY Change 29.18% 56.42% 47.91%
Depreciation, Depletion And Amortization $1.200M $1.700M $6.300M
YoY Change -20.0% 31.99% 31.25%
Cash From Operating Activities -$91.20M -$71.20M -$273.5M
YoY Change 59.72% 99.13% -148.89%
INVESTING ACTIVITIES
Capital Expenditures $1.100M $1.100M $6.800M
YoY Change -47.62% -158.05% 44.68%
Acquisitions
YoY Change
Other Investing Activities $139.7M $20.50M $249.6M
YoY Change 1205.61% -118.02% -119.07%
Cash From Investing Activities $138.6M $19.40M $242.8M
YoY Change 1511.63% -116.78% -118.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities $1.500M 500.0K $4.700M
YoY Change -40.0% -87.5% -98.31%
NET CHANGE
Cash From Operating Activities -$91.20M -71.20M -$273.5M
Cash From Investing Activities $138.6M 19.40M $242.8M
Cash From Financing Activities $1.500M 500.0K $4.700M
Net Change In Cash $48.90M -51.30M -$26.00M
YoY Change -206.3% -65.19% -94.53%
FREE CASH FLOW
Cash From Operating Activities -$91.20M -$71.20M -$273.5M
Capital Expenditures $1.100M $1.100M $6.800M
Free Cash Flow -$92.30M -$72.30M -$280.3M
YoY Change 55.91% 113.53% -150.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001655759
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-38672
CY2022 dei Entity Registrant Name
EntityRegistrantName
ARVINAS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2566120
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Science Park
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
395 Winchester Ave
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New Haven
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06511
CY2022 dei City Area Code
CityAreaCode
203
CY2022 dei Local Phone Number
LocalPhoneNumber
535-1456
CY2022 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
ARVN
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
2175700000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53271491 shares
CY2022 dei Auditor Firm
AuditorFirmId
34
CY2022 dei Auditor Firm
AuditorFirmId
34
CY2022 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2022 dei Auditor Location
AuditorLocation
Stamford, Connecticut
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81300000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108300000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5500000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
4500000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1124000000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1394300000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000.0 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7000000.0 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
10700000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21400000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19700000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1240200000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1552500000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13400000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12700000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4400000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3900000 usd
CY2022Q4 arvn Collaboration Contract Asset And Other Assets
CollaborationContractAssetAndOtherAssets
10800000 usd
CY2021Q4 arvn Collaboration Contract Asset And Other Assets
CollaborationContractAssetAndOtherAssets
12500000 usd
CY2022Q4 us-gaap Assets
Assets
1268800000 usd
CY2021Q4 us-gaap Assets
Assets
1581600000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
74700000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54400000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
218600000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
206200000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1800000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
295100000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
261700000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
405100000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
534300000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000.0 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000.0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2700000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2900000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
703900000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
799900000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53200000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53200000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53000000.0 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53000000.0 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-965400000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-682900000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1549400000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1469200000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19200000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4600000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
564900000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
781700000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1268800000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1581600000 usd
CY2022 us-gaap Revenues
Revenues
131400000 usd
CY2021 us-gaap Revenues
Revenues
53600000 usd
CY2020 us-gaap Revenues
Revenues
25900000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
315000000.0 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
180400000 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108400000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
79600000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61600000 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38300000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
394600000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
242000000.0 usd
CY2020 us-gaap Operating Expenses
OperatingExpenses
146700000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-263200000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-188400000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-120800000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2500000 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2100000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000000.0 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1800000 usd
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
3500000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12200000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4300000 usd
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5600000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-251000000.0 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-184100000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-115200000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20900000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10600000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6900000 usd
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4100000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-282500000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.31
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.31
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.82
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.02
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.02
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53200000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53200000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39500000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39500000 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-282500000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 usd
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-14500000 usd
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5200000 usd
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
500000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-297000000.0 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-196200000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-118800000 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
226600000 usd
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
28100000 usd
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
431900000 usd
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30200000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 usd
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8200000 usd
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
500000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
642200000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57100000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18700000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4600000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
259900000 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5200000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
781700000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75500000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-282500000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4800000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14600000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
564900000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-282500000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6300000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4800000 usd
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000 usd
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-5700000 usd
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-9400000 usd
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1700000 usd
CY2022 arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
0 usd
CY2021 arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
1000000.0 usd
CY2020 arvn Debt Instrument Loan Forgiveness
DebtInstrumentLoanForgiveness
0 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-400000 usd
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-200000 usd
CY2020 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
400000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1900000 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1200000 usd
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
900000 usd
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1800000 usd
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
400000 usd
CY2020 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
75500000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
57100000 usd
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
30200000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-14000000.0 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14000000.0 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000000.0 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-3700000 usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
3300000 usd
CY2020 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1200000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1800000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13600000 usd
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2400000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
12900000 usd
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20200000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
27900000 usd
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12800000 usd
CY2022 arvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1900000 usd
CY2021 arvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1300000 usd
CY2020 arvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-900000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-116800000 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
695500000 usd
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13300000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-273500000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
559400000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89700000 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
886400000 usd
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1744600000 usd
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
41200000 usd
CY2022 arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
1076900000 usd
CY2021 arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
428500000 usd
CY2020 arvn Proceeds From Maturities Of Marketable Securities
ProceedsFromMaturitiesOfMarketableSecurities
174100000 usd
CY2022 arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
59100000 usd
CY2021 arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
7200000 usd
CY2020 arvn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
37800000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6800000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4700000 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6400000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
242800000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1313600000 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
164300000 usd
CY2022 arvn Proceeds From Issuance Of Common Stock In A Public Offering
ProceedsFromIssuanceOfCommonStockInAPublicOffering
0 usd
CY2021 arvn Proceeds From Issuance Of Common Stock In A Public Offering
ProceedsFromIssuanceOfCommonStockInAPublicOffering
264600000 usd
CY2020 arvn Proceeds From Issuance Of Common Stock In A Public Offering
ProceedsFromIssuanceOfCommonStockInAPublicOffering
460000000.0 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4600000 usd
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
27700000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4700000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18600000 usd
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8300000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4700000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
278600000 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
504600000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26000000.0 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-475600000 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
579200000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112800000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588400000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9200000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86800000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112800000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588400000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
500000 usd
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
500000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
100000 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
100000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11100000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 arvn Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
4 subsidiary
CY2022Q4 arvn Cash Cash Equivalents Restricted Cash And Marketable Securities
CashCashEquivalentsRestrictedCashAndMarketableSecurities
1200000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81300000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108300000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588400000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5500000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
4500000 usd
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86800000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112800000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588400000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit Risk The Company maintains its cash in financial institution accounts that may at times exceed federally insured limits. The cash balances in the financial institutions are insured by the Federal Deposit Insurance Corporation ("FDIC") up to $250,000. Cash may also be maintained at commercial institutions that are not insured by the FDIC.
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operating_segment
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12500000 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2200000 usd
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000 usd
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000.0 usd
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 usd
CY2022 arvn Accounts Receivable After Allowance For Credit Loss Current Additions
AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions
6400000 usd
CY2021 arvn Accounts Receivable After Allowance For Credit Loss Current Additions
AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions
19900000 usd
CY2022 arvn Accounts Receivable After Allowance For Credit Loss Current Payments Received
AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived
20400000 usd
CY2021 arvn Accounts Receivable After Allowance For Credit Loss Current Payments Received
AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived
5900000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1000000.0 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000.0 usd
CY2021Q4 arvn Accounts Payable Contract Balances Current
AccountsPayableContractBalancesCurrent
0 usd
CY2020Q4 arvn Accounts Payable Contract Balances Current
AccountsPayableContractBalancesCurrent
0 usd
CY2022 arvn Accounts Payable Contract Balances Current Additions
AccountsPayableContractBalancesCurrentAdditions
5000000.0 usd
CY2021 arvn Accounts Payable Contract Balances Current Additions
AccountsPayableContractBalancesCurrentAdditions
0 usd
CY2022 arvn Accounts Payable Contract Balances Current Payments
AccountsPayableContractBalancesCurrentPayments
0 usd
CY2021 arvn Accounts Payable Contract Balances Current Payments
AccountsPayableContractBalancesCurrentPayments
0 usd
CY2022Q4 arvn Accounts Payable Contract Balances Current
AccountsPayableContractBalancesCurrent
5000000.0 usd
CY2021Q4 arvn Accounts Payable Contract Balances Current
AccountsPayableContractBalancesCurrent
0 usd
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022 arvn Contract With Customer Assets Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements
0 usd
CY2021 arvn Contract With Customer Assets Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements
12900000 usd
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1800000 usd
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
400000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10700000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12500000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
740500000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
45100000 usd
CY2022 arvn Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements
4000000.0 usd
CY2021 arvn Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements
ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements
742100000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-120000000.0 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-18600000 usd
CY2022 arvn Contract With Customer Liability Revenue Recognized Not Included In Previous Balance
ContractWithCustomerLiabilityRevenueRecognizedNotIncludedInPreviousBalance
-800000 usd
CY2021 arvn Contract With Customer Liability Revenue Recognized Not Included In Previous Balance
ContractWithCustomerLiabilityRevenueRecognizedNotIncludedInPreviousBalance
-28100000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
623700000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
740500000 usd
CY2022 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
700000 usd
CY2021 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
-800000 usd
CY2020 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
-400000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
623700000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
218600000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
193900000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
90200000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
55300000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
34700000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
31000000.0 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
623700000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30000000.0 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23400000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16600000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10700000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13400000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12700000 usd
CY2022 us-gaap Depreciation
Depreciation
6300000 usd
CY2021 us-gaap Depreciation
Depreciation
4800000 usd
CY2020 us-gaap Depreciation
Depreciation
3200000 usd
CY2021Q2 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
160000 sqft
CY2021Q2 arvn Base Lease Rent Period
BaseLeaseRentPeriod
P10Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
2100000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1400000 usd
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1000000.0 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1900000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1200000 usd
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
900000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2400000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3200000 usd
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
600000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2000000.0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2200000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
500000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4700000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
200000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4500000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5700000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31300000 usd
CY2022Q4 arvn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
35900000 usd
CY2021Q4 arvn Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
9500000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18700000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12400000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
10300000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4100000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1200000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
74700000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54400000 usd
CY2018Q2 arvn Percentage Of Maximum Funding On Project Costs
PercentageOfMaximumFundingOnProjectCosts
0.50
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
200000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
200000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
200000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
200000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
200000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1000000.0 usd
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
100000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 arvn Number Of Votes Per Common Stock Share Held
NumberOfVotesPerCommonStockShareHeld
1 vote
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75500000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57100000 usd
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30200000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
67300000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
39.17
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
52.85
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.45
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7900000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
46900000 usd
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
19400000 usd
CY2021 us-gaap Revenues
Revenues
53600000 usd
CY2020 us-gaap Revenues
Revenues
25900000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-188400000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-120800000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6900000 usd
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4100000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 usd
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.82
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.02
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.02
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-196200000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-118800000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10600000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6900000 usd
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4100000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20900000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8200000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12700000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20900000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20900000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 arvn Effective Income Tax Rate Reconciliation Return To Provision Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent
0.036
CY2021 arvn Effective Income Tax Rate Reconciliation Return To Provision Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent
0.011
CY2020 arvn Effective Income Tax Rate Reconciliation Return To Provision Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.034
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.027
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.041
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.012
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.027
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.017
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.016
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.163
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.317
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.384
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.233
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.080
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
143000000.0 usd
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10000000.0 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
56300000 usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
25900000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15400000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10400000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
18800000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3800000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
97000000.0 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7700000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3300000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
247100000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
144500000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2600000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3600000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1000000.0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1400000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3600000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5000000.0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
243500000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
139500000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4100000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4100000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
0 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1600000 usd
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1800000 usd
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.82
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
7000000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-282500000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-191000000.0 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-119300000 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53200000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53200000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50000000.0 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39500000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39500000 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.31
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.31
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.82
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.02
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.02
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7300000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5400000 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4600000 shares

Files In Submission

Name View Source Status
0001655759-23-000010-index-headers.html Edgar Link pending
0001655759-23-000010-index.html Edgar Link pending
0001655759-23-000010.txt Edgar Link pending
0001655759-23-000010-xbrl.zip Edgar Link pending
arvinaspfizzeramendmentno3.htm Edgar Link pending
arvn-20221231.htm Edgar Link pending
arvn-20221231.xsd Edgar Link pending
arvn-20221231x10kxex21_1.htm Edgar Link pending
arvn-20221231x10kxex311.htm Edgar Link pending
arvn-20221231x10kxex312.htm Edgar Link pending
arvn-20221231x10kxex321.htm Edgar Link pending
arvn-20221231x10kxex322.htm Edgar Link pending
arvn-20221231_g1.jpg Edgar Link pending
arvn-20221231_g10.jpg Edgar Link pending
arvn-20221231_g11.jpg Edgar Link pending
arvn-20221231_g12.jpg Edgar Link pending
arvn-20221231_g2.jpg Edgar Link pending
arvn-20221231_g3.jpg Edgar Link pending
arvn-20221231_g4.jpg Edgar Link pending
arvn-20221231_g5.jpg Edgar Link pending
arvn-20221231_g6.jpg Edgar Link pending
arvn-20221231_g7.jpg Edgar Link pending
arvn-20221231_g8.jpg Edgar Link pending
arvn-20221231_g9.jpg Edgar Link pending
consent-form10kfy22.htm Edgar Link pending
exhibit1034arvinasbayeroer.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
arvn-20221231_cal.xml Edgar Link unprocessable
arvn-20221231_def.xml Edgar Link unprocessable
arvn-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arvn-20221231_pre.xml Edgar Link unprocessable
arvn-20221231_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending